Aclaris Therapeutics, Inc 10-K for FY2020
Aclaris Therapeutics, Inc. (ACRS)
10-K
2021-02-25
For: 2020-12-31
View Original
Added on
April 08, 2026
About this 10-K
Aclaris Therapeutics, Inc filed this 10-K on February 25, 2021, covering the fiscal year ended December 31, 2020 (FY2020).
Headline figures
Fiscal year ended December 31, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.48M
- up 53.3% from $4.23M a year earlier
- Net loss
- $51.02M
- compared with a net loss of $161.35M a year earlier